In 2023, PLA launched an eLeaflet solution – ePI by PharmaLedger™ – developed with patients to deliver a user-centric eLeaflet experience which is easy to access and read. To access ePI by PharmaLedger™, the user scans the QR code (1) to launch a web app, then follows instructions to scan the 2D Data Matrix Code (2) to get their leaflet. For user convenience, a QR code is provided on the pack so users can get the app (1).
DIGITAL LABELLING EVOLUTION
AstraLabel™ & ePI by PharmaLedger™
DIGITAL LABELLING EVOLUTION
AstraLabel™ & ePI by PharmaLedger™
ePI by Pharmaledger™
AstraLabel™
PLA’s scalable digital labelling platform that delivers real-time SmPC, ePIL and labelling content directly to packaging, portals, and patient devices.
Singapore, South Korea, Canada, Ecuador, UAE, Chile, Belgium and India are some of the countries already benefiting from the global standard ePI solution. 2025 expansion: Turkey and Brazil.
Today, ePI by PharmaLedger™ is used by pharmaceutical companies to provide eLeaflets to Patients and Healthcare Practitioners across the world, currently ensuring readiness in 46 countries and in 29 languages and serving as the cornerstone of the AstraLabel platform.
ePI by Pharmaledger™
In 2023, PLA launched an eLeaflet solution – ePI by PharmaLedger™ – developed with patients to deliver a user-centric eLeaflet experience which is easy to access and read. To access ePI by PharmaLedger™, the user scans the QR code (1) to launch a web app, then follows instructions to scan the 2D Data Matrix Code (2) to get their leaflet. For user convenience, a QR code is provided on the pack so users can get the app (1).
Singapore, South Korea, Canada, Ecuador, UAE, Chile, Belgium and India are some of the countries already benefiting from the global standard ePI solution. 2025 expansion: Turkey and Brazil.
Today, ePI by PharmaLedger™ is used by pharmaceutical companies to provide eLeaflets to Patients and Healthcare Practitioners across the world, currently ensuring readiness in 46 countries and in 29 languages and serving as the cornerstone of the AstraLabel platform.
AstraLabel™
PLA’s scalable digital labelling platform that delivers real-time SmPC, ePIL and labelling content directly to packaging, portals, and patient devices.
Access to the most current and approved product information
All features available in Portrait or landscape format for mobiles and tablets
LIGHTWEIGHT AND PRIVATE
MULTI LANGUAGES
TEXT TO SPEECH FUNCTIONALITY
FONT SIZE ADJUSTABILITY
Lightweight App that does not require download or sign in
Available in multiple languages unlike paper leaflets
Our app supports text to speech to increase accessibility
The font size can be changed up to 300% for better reading
Access to the most current and approved product information
All features available in Portrait or landscape format for mobiles and tablets
LIGHTWEIGHT AND PRIVATE
Lightweight App that does not require download or sign in
MULTI LANGUAGES
Available in multiple languages unlike paper leaflets
TEXT TO SPEECH FUNCTIONALITY
Our app supports text to speech to increase accessibility
FONT SIZE ADJUSTABILITY
The font size can be changed up to 300% for better reading
Accessibility Compliant, Tailored for user, Paperless Ready
ELEAFLET TYPE
PRINTING FEATURE
RECALL NOTIFICATIONS
For patients, a clear, easy-to-understand and user interactive. For healthcare professionals, quick access to pharmacological data and guidelines.
To promote equal access incorporating a printing feature is essential to bridge the digital divide
Recall Notifications prevents patients from continuing to use a potentially dangerous medication
Accessibility Compliant, Tailored for user, Paperless Ready
Additional features tailored for the Brazilian market, in collaboration with Brazilian regulatory authorities and leading pharmas.
ELEAFLET TYPE
For patients, a clear, easy-to-understand and user interactive. For healthcare professionals, quick access to pharmacological data and guidelines.
PRINTING FEATURE
To promote equal access incorporating a printing feature is essential to bridge the digital divide
RECALL NOTIFICATIONS
Recall Notifications prevents patients from continuing to use a potentially dangerous medication
AstraLabel™ & ePI by PharmaLedger™
How they work together
AstraLabel™ Deployment models
A Trusted Digital Bridge for the Future
A scalable digital labelling platform that delivers real-time SmPC, ePIL, and labelling content directly to packaging, portals, and patient devices.
Built for full regulatory traceability and zero-paper delivery, it supports pharma companies of every size with flexible deployments: Core, Solo, and Edge.
ePI by PharmaLedger™
Built for compliance. Ready for scale.
From approval to patient in seconds.
ePI by PharmaLedger™ is the front end of the solution and included in any of the AstraLabel™ deployment models. Together they create a secure, scalable digital connection between manufacturers, regulators, and patients.
AstraLabel™ + ePI by PharmaLedger™
How they work together
AstraLabel™ Deployment models
A Trusted Digital Bridge for the Future
A scalable digital labelling platform that delivers real-time SmPC, ePIL, and labelling content directly to packaging, portals, and patient devices.
Built for full regulatory traceability and zero-paper delivery, it supports pharma companies of every size with flexible deployments: Core, Solo, and Edge.
+
ePI by PharmaLedger™
Built for compliance. Ready for scale.
From approval to patient in seconds.
Together, AstraLabel™ and Epi create a secure, scalable digital connection between manufacturers, regulators, and patients.
1.
PLA AstraLabel™
CORE
Suitable for decentralised organisations and small to medium pharma companies looking to deploy on a country-by-country basis.
Secure shared environment
PLA handles infrastructure and uploads
XML conversion included
Manual data and leaflet uploads
Ideal for minimal IT engagement
Ready in 1 month
Setup fee CHF 18,750 + per leaflet CHF 2,250
Starting from January 2026
2.
PLA AstraLabel™
SOLO
Suitable for pharma companies looking to standardise regionally or globally and require scalability and centralised processing.
Secure dedicated environment
No customer side setup
XML conversion optional extra
Customer manages uploads and accesses
API Access Available
Ready in 1–2 months
Monthly fee CHF 15,000
Starting from January 2026
3.
PLA AstraLabel™
EDGE
Suitable for companies who have strict data segregation or localisation requirements who prefer an on-premise delivery model.
Self-hosted infrastructure
Setup supported by PLA
XML conversion optional extra
Customer manages leaflet content
API driven integration to SOR*
Readiness driven by customer timeline
Membership fee + monthly fee CHF 20,000
* SAP, Veeva, JDE etc
1.
PLA AstraLabel™
CORE
Suitable for decentralised organisations and small to medium pharma companies looking to deploy on a country-by-country basis.
Secure shared environment
PLA handles infrastructure and uploads
XML conversion included
Manual data and leaflet uploads
Ideal for minimal IT engagement
Ready in 1 month
Setup fee CHF 18,750 + per leaflet CHF 2,250
Starting from January 2026
2.
PLA AstraLabel™
SOLO
Suitable for pharma companies looking to standardise regionally or globally and require scalability and centralised processing.
Secure dedicated environment
No customer side setup
XML conversion optional extra
Customer manages uploads and accesses
API Access Available
Ready in 1–2 months
Monthly fee CHF 15,000
Starting from January 2026
3.
PLA AstraLabel™
EDGE
Suitable for companies who have strict data segregation or localisation requirements who prefer an on-premise delivery model.
Self-hosted infrastructure
Setup supported by PLA
XML conversion optional extra
Customer manages leaflet content
API driven integration to SOR*
Readiness driven by customer timeline
Membership fee + monthly fee CHF 20,000
* SAP, Veeva, JDE etc
Feedback Results | Patients
Data collected from Patients Surveys where participants rated their satisfaction on a scale from 1 to 5.
Access the full report here
Feedback Results | Healthcare Professionals
Data collected from Healthcare Professionals Surveys where participants rated their satisfaction on a scale from 1 to 5.
Access the full report here
Feedback Results | Patients
Data collected from Patients Surveys where participants rated their satisfaction on a scale from 1 to 5.
Access the full report here
Feedback Results | Healthcare Professionals
Data collected from Healthcare Professionals Surveys where participants rated their satisfaction on a scale from 1 to 5.
Access the full report here
HOW DOES IT WORK?
ePI by PharmaLedger™ is accessible through a scan of the barcode on the product package. The scan reads the “GTIN” or Global Trade Identification Number and the batch and uses blockchain as a resolver to determine the correct MAH of the product.
The application then provides the patient or HCP with Product Information directly from the marketing authorization holder (MAH). The latest approved version of the Product Information is then provided to the user.
The barcode on the product can also provide additional information such as the validity of the expiry date and serial number. These can also be checked to verify the product packaging.
It’s important that at no point is patient or user information captured. The patient’s use of the app to identify the product and access the information is private information. The product owner will not have any scan information to identify the user in any way, as this is private information.
HOW DOES IT WORK?
ePI by PharmaLedger™ is accessible through a scan of the barcode on the product package. The scan reads the “GTIN” or Global Trade Identification Number and the batch and uses blockchain as a resolver to determine the correct MAH of the product.
The application then provides the patient or HCP with Product Information directly from the marketing authorization holder (MAH). The latest approved version of the Product Information is then provided to the user.
The barcode on the product can also provide additional information such as the validity of the expiry date and serial number. These can also be checked to verify the product packaging.
It’s important that at no point is patient or user information captured. The patient’s use of the app to identify the product and access the information is private information. The product owner will not have any scan information to identify the user in any way, as this is private information.
Discover More about AstraLabel™ & ePI by PharmaLedger™
If you want to know more, please contact us. We look forward to finding the right solution for you and we are ready support your next step into the Digital Trust Ecosystem for healthcare.
Sign up for our newsletter
All Rights Reserved © 2025 PharmaLedger Association